GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
Multiple GLP-1-derived therapeutics are clinically used to treat type 2 diabetes and obesity. However, the underlying mechanism of how these drugs regulate the body weight of obese patients remains incompletely understood. Here, we report that the lipolysis effects of GLP-1 on β cells can depend on...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7bdb554328d646d6b1fcf7fdac2da5a2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|